Beaumont, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Benign Essential Blepharospasm Research Foundation Inc, founded in 1981, is a small nonprofit in the Medical Research sector that reported $809K in total revenue in fiscal year 2024. Revenue surged 91% from the prior year, signaling strong growth momentum. The organization ran a surplus of $564K, a strong 70% operating margin.
Education and research funding pertaining to benign essential blepharospasm and related conditions
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $809,169 | $423,809 | +0.9% |
| Expenses | $244,743 | $241,465 | +0.0% |
| Net Income | $564,426 | $182,344 | +2.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Heidi Coggeshall | President | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Brenda Rarick | Treasurer | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Peter Bakalor | VP of Development | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Eda Tekeoglu | Vice President | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Tishana Cundiff | VP - Education & Support | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jonathan Healy | Director | 0.50 |
Director
|
$0 | $0 | $0 |
| Carlas Powell | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Bryan Renehan | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Cynthia Clark | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Gina Duvasaint | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Christopher West | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Charlene Hudgins | Executive Director | 40.00 |
Key Emp
|
$59,500 | $0 | $59,500 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $809,169 | $244,743 | $2,691,107 | $564,426 |
| 2022 | $370,429 | $223,613 | $1,832,628 | $146,816 |
| 2021 | $511,633 | $202,844 | $1,823,419 | $308,789 |
| 2020 | $174,275 | $292,130 | $1,500,213 | $-117,855 |
| 2019 | $264,958 | $327,096 | $1,580,335 | $-62,138 |
| 2018 | $248,139 | $360,946 | $1,579,461 | $-112,807 |
Compare Benign Essential Blepharospasm Research Foundation Inc with other nonprofits in Texas and across the country.